 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$22.65 |
$22.78 |
$20.43 |
$20.66 |
77.60K | | 04/16/2024 |
$20.75 |
$21.88 |
$20.75 |
$21.25 |
141.20K | | 04/17/2024 |
$21.51 |
$21.78 |
$20.94 |
$21.56 |
121.80K | | 04/18/2024 |
$21.75 |
$22.39 |
$21.50 |
$22.02 |
124.60K | | 04/19/2024 |
$21.76 |
$23.18 |
$21.76 |
$22.64 |
305.70K |
|
|
| Silence Therapeutics is a biotechnology company focused on discovering and developing molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with unmet medical need. Co.'s wholly owned pipeline is focused in three therapeutic areas of unmet need: cardiovascular disease, hematology and rare diseases. Co.'s wholly owned product candidates are: SLN360, which is an siRNA molecule designed for the treatment of cardiovascular disease associated with elevated Lp(a), a lipoprotein in the blood; and SLN124, which is an siRNA molecule designed to treat erythropoiesis. | |
|
Silence Therapeutics (SLN) has the following price history information. Looking back at SLN historical stock prices for the last five trading days, on April 15, 2024, SLN opened at $22.65, traded as high as $22.78 and as low as $20.43, and closed at $20.66. Trading volume was a total of 77.60K shares. On April 16, 2024, SLN opened at $20.75, traded as high as $21.88 and as low as $20.75, and closed at $21.25. Trading volume was a total of 141.20K shares. On April 17, 2024, SLN opened at $21.51, traded as high as $21.78 and as low as $20.94, and closed at $21.56. Trading volume was a total of 121.80K shares. On April 18, 2024, SLN opened at $21.75, traded as high as $22.39 and as low as $21.50, and closed at $22.02. Trading volume was a total of 124.60K shares. On April 19, 2024, SLN opened at $21.76, traded as high as $23.18 and as low as $21.76, and closed at $22.64. Trading volume was a total of 305.70K shares.
SLN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Silence Therapeutics shares, starting with a $10,000 purchase of SLN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/09/2020 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$19.00 |
|
| End price/share: |
$22.64 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
19.16% |
|
| Average Annual Total Return: |
4.97% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,914.22 |
|
| Years: |
3.61 |
|
|
|
| Date |
Close |
| 04/15/2024 | $20.66 | | 04/16/2024 | $21.25 | | 04/17/2024 | $21.56 | | 04/18/2024 | $22.02 | | 04/19/2024 | $22.64 |
|
|
